217 related articles for article (PubMed ID: 9854591)
1. The variable penetrance and spectrum of manifestations of multiple endocrine neoplasia type 1.
Carty SE; Helm AK; Amico JA; Clarke MR; Foley TP; Watson CG; Mulvihill JJ
Surgery; 1998 Dec; 124(6):1106-13; discussion 1113-4. PubMed ID: 9854591
[TBL] [Abstract][Full Text] [Related]
2. Age-related penetrance of endocrine tumours in multiple endocrine neoplasia type 1 (MEN1): a multicentre study of 258 gene carriers.
Machens A; Schaaf L; Karges W; Frank-Raue K; Bartsch DK; Rothmund M; Schneyer U; Goretzki P; Raue F; Dralle H
Clin Endocrinol (Oxf); 2007 Oct; 67(4):613-22. PubMed ID: 17590169
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis and treatment of multiple endocrine neoplasia type 1 (MEN1).
Gaztambide S; Vazquez F; Castaño L
Minerva Endocrinol; 2013 Mar; 38(1):17-28. PubMed ID: 23435440
[TBL] [Abstract][Full Text] [Related]
4. [Multiple Endocrine Neoplasia I (Wermers Syndrome), Forms of Clinical Manifestation, 5 Case Studies].
Drbalová K; Herdová K; Krejčí P; Nývltová M; Solař S; Vedralová L; Záruba P; Netuka D; Bavor P
Vnitr Lek; 2016; 62(9 Suppl 3):140-149. PubMed ID: 27734708
[TBL] [Abstract][Full Text] [Related]
5. Causes of death and prognostic factors in multiple endocrine neoplasia type 1: a prospective study: comparison of 106 MEN1/Zollinger-Ellison syndrome patients with 1613 literature MEN1 patients with or without pancreatic endocrine tumors.
Ito T; Igarashi H; Uehara H; Berna MJ; Jensen RT
Medicine (Baltimore); 2013 May; 92(3):135-181. PubMed ID: 23645327
[TBL] [Abstract][Full Text] [Related]
6. Multiple endocrine neoplasia type 1.
Marini F; Falchetti A; Del Monte F; Carbonell Sala S; Gozzini A; Luzi E; Brandi ML
Orphanet J Rare Dis; 2006 Oct; 1():38. PubMed ID: 17014705
[TBL] [Abstract][Full Text] [Related]
7. Acromegaly in a multiple endocrine neoplasia type 1 (MEN1) family with low penetrance of the disease.
Dreijerink KM; van Beek AP; Lentjes EG; Post JG; van der Luijt RB; Canninga-van Dijk MR; Lips CJ
Eur J Endocrinol; 2005 Dec; 153(6):741-6. PubMed ID: 16322378
[TBL] [Abstract][Full Text] [Related]
8. Multiple endocrine neoplasia type 1: extensive analysis of a large database of Florentine patients.
Marini F; Giusti F; Brandi ML
Orphanet J Rare Dis; 2018 Nov; 13(1):205. PubMed ID: 30428914
[TBL] [Abstract][Full Text] [Related]
9. Clinical studies of multiple endocrine neoplasia type 1 (MEN1).
Trump D; Farren B; Wooding C; Pang JT; Besser GM; Buchanan KD; Edwards CR; Heath DA; Jackson CE; Jansen S; Lips K; Monson JP; O'Halloran D; Sampson J; Shalet SM; Wheeler MH; Zink A; Thakker RV
QJM; 1996 Sep; 89(9):653-69. PubMed ID: 8917740
[TBL] [Abstract][Full Text] [Related]
10. Understanding the clinical course of genotype-negative MEN1 patients can inform management strategies.
Pieterman CRC; Hyde SM; Wu SY; Landry JP; Chiang YJ; Christakis I; Grubbs EG; Fisher SB; Graham PH; Waguespack SG; Perrier ND
Surgery; 2021 Jan; 169(1):175-184. PubMed ID: 32703679
[TBL] [Abstract][Full Text] [Related]
11. Multiple endocrine neoplasia type 1 in Poland: a two-centre experience.
Soczomski P; Jurecka-Lubieniecka B; Rogozik N; Tukiendorf A; Jarząb B; Bednarczuk T
Endokrynol Pol; 2019; 70(5):385-391. PubMed ID: 31274185
[TBL] [Abstract][Full Text] [Related]
12. Multiple endocrine neoplasia type 1 in Japan: establishment and analysis of a multicentre database.
Sakurai A; Suzuki S; Kosugi S; Okamoto T; Uchino S; Miya A; Imai T; Kaji H; Komoto I; Miura D; Yamada M; Uruno T; Horiuchi K; Miyauchi A; Imamura M; ; Fukushima T; Hanazaki K; Hirakawa S; Igarashi T; Iwatani T; Kammori M; Katabami T; Katai M; Kikumori T; Kiribayashi K; Koizumi S; Midorikawa S; Miyabe R; Munekage T; Ozawa A; Shimizu K; Sugitani I; Takeyama H; Yamazaki M
Clin Endocrinol (Oxf); 2012 Apr; 76(4):533-9. PubMed ID: 21950691
[TBL] [Abstract][Full Text] [Related]
13. Multiple endocrine neoplasia type 1 in Northern Finland; clinical features and genotype phenotype correlation.
Vierimaa O; Ebeling TM; Kytölä S; Bloigu R; Eloranta E; Salmi J; Korpi-Hyövälti E; Niskanen L; Orvola A; Elovaara E; Gynther A; Sane T; Välimäki M; Ignatius J; Leisti J; Salmela PI
Eur J Endocrinol; 2007 Sep; 157(3):285-94. PubMed ID: 17766710
[TBL] [Abstract][Full Text] [Related]
14. Multiple endocrine neoplasia type 1 (MEN1): its manifestations and effect of genetic screening on clinical outcome.
Pieterman CR; Schreinemakers JM; Koppeschaar HP; Vriens MR; Rinkes IH; Zonnenberg BA; van der Luijt RB; Valk GD
Clin Endocrinol (Oxf); 2009 Apr; 70(4):575-81. PubMed ID: 18616711
[TBL] [Abstract][Full Text] [Related]
15. MEN1 clinical background.
Igaz P
Adv Exp Med Biol; 2009; 668():1-15. PubMed ID: 20175448
[TBL] [Abstract][Full Text] [Related]
16. Multiple endocrine neoplasia type 1 (MEN1) in Austria.
Weinhäusel A; Kaserer K; Vierhapper H; Niederle B; Haas OA;
Wien Klin Wochenschr; 2002 Apr; 114(7):252-7. PubMed ID: 12089860
[TBL] [Abstract][Full Text] [Related]
17. Multiple endocrine neoplasia type 1: fresh perspective on clinical features and penetrance.
Glascock MJ; Carty SE
Surg Oncol; 2002 Nov; 11(3):143-50. PubMed ID: 12356510
[TBL] [Abstract][Full Text] [Related]
18. Type 1 multiple endocrine neoplasia (MEN1): contribution of genetic analysis to the screening and follow-up of a large French kindred.
Waterlot C; Porchet N; Bauters C; Decoulx M; Wémeau JL; Proye C; Degand PM; Aubert JP; Cortet C; Dewailly D
Clin Endocrinol (Oxf); 1999 Jul; 51(1):101-7. PubMed ID: 10468972
[TBL] [Abstract][Full Text] [Related]
19. [Hereditary variants of primary hyperparathyroidism--MEN1, MEN2, HPT-JT, FHH, FIHPT].
Frank-Raue K; Leidig-Bruckner G; Lorenz A; Rondot S; Haag C; Schulze E; Büchler M; Raue F
Dtsch Med Wochenschr; 2011 Sep; 136(38):1889-94. PubMed ID: 21915802
[TBL] [Abstract][Full Text] [Related]
20. Thymic carcinoids in multiple endocrine neoplasia type 1.
Teh BT; Zedenius J; Kytölä S; Skogseid B; Trotter J; Choplin H; Twigg S; Farnebo F; Giraud S; Cameron D; Robinson B; Calender A; Larsson C; Salmela P
Ann Surg; 1998 Jul; 228(1):99-105. PubMed ID: 9671073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
